Inmune Bio (INMB) Shares Outstanding (2017 - 2026)

Inmune Bio has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $26.6 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 15.94% year-over-year to $26.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.6 million (up 15.94% YoY) and the FY2025 annual result came in at $26.6 million, up 19.32% from the prior year.
• Shares Outstanding (Entity) held at $26.6 million in Q1 2026 per INMB's latest filing, from $26.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $26.6 million in Q2 2025 and troughed at $17.9 million in Q1 2022.
• A 5-year average of $20.9 million and a median of $18.0 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) changed 0.0% in 2023, then jumped 34.9% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $17.9 million in 2022, then rose by 0.03% to $18.0 million in 2023, then advanced by 24.12% to $22.3 million in 2024, then gained by 19.32% to $26.6 million in 2025, then changed by 0.0% to $26.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $26.6 million, $26.6 million, and $26.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.